US EditionPublished • loading... • Updated
India - Grant Romiplostim Lyophilized Formulations Patent With Amendments: Madras High Court Directs. - Conventus Law
Summary by Conventus Law
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
India - Grant Romiplostim Lyophilized Formulations Patent With Amendments: Madras High Court Directs. - Conventus Law
The judgment issued by the Madras High Court in the patent dispute between Amgen and Intas has determined that the invention related to the lyophilisation of Romiplostim meets the criteria for inventiveness. Furthermore, the Court concluded that the claimed invention was not subject to exclusion from patent protection under Sections 3(d) or 3(e) of the Patents Act, 1970. Setting aside the order of the Controller, the Court directed patent applic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
